Cargando…
A Novel Approach to the Treatment of Pembrolizumab-induced Psoriasis Exacerbation: A Case Report
While immune checkpoint inhibitors have been groundbreaking for cancer treatment, there are many reported cases of patients undergoing immunotherapy who have discontinued or temporarily interrupted treatment due to the development of autoimmune-related adverse effects. Here, we present a 63-year-old...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Cureus
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6827694/ https://www.ncbi.nlm.nih.gov/pubmed/31754559 http://dx.doi.org/10.7759/cureus.5824 |